Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy

Amara, 1998, Neurotransmitter transporters as molecular targets for addictive drugs, Drug Alcohol Depend, 51, 87, 10.1016/S0376-8716(98)00068-4 Amphoux, 2006, Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain, Neuropharmacology, 50, 941, 10.1016/j.neuropharm.2006.01.005 Arndt, 2001, Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1, Am J Physiol Renal Physiol, 281, F454, 10.1152/ajprenal.2001.281.3.F454 Artigas, 1996, Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists, Trends Neurosci, 19, 378, 10.1016/S0166-2236(96)10037-0 Baganz, N. L., Horton, R. E., Calderon, A. S., Owens, W. A., Munn, J. L., Watts, L. T., et al. (2008). Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin transporter deficient mice. Proc Nat Acad Sci USA. Bannon, 2001, The human dopamine transporter gene: Gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders, Eur Neuropsychopharmacol, 11, 449, 10.1016/S0924-977X(01)00122-5 Bennet, 2002, Early experience and serotonin transporter gene variation interact to influence primate CNS function, Mol Psychiatry, 7, 118, 10.1038/sj/mp/4000949 Bertler, 1964, Studies on 5-hydroxytryptamine stores in pineal gland of rat, Acta Physiol Scand Suppl, 239, 1, 10.1111/j.1748-1716.1964.tb04118.x Blakely, 2000, Biogenic amine transporters: regulation in flux, Curr Opin Neurobiol, 10, 328, 10.1016/S0959-4388(00)00088-X Blakely, 1991, Cloning and expression of a functional serotonin transporter from rat brain, Nature, 354, 66, 10.1038/354066a0 Blakely, 2005, Biogenic amine neurotransmitter transporters: just when you thought you knew them, Physiology, 20, 225, 10.1152/physiol.00013.2005 Blakely, 1998, Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins, Biol Psychiatry, 44, 169, 10.1016/S0006-3223(98)00124-3 Blier, 1987, Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression, J Clin Psychopharmacol, 7, 24S, 10.1097/00004714-198712001-00003 Bönisch, 2006, The norepinephrine transporter in physiology and disease, Handb Exp Pharmacol, 175, 485, 10.1007/3-540-29784-7_20 Borland, L. M., & Michael, A. C. (2007). An introduction to electrochemical methods in neuroscience. In A. C. Michael & L. M. Borland (Eds.), Electrochemical Methods in Neuroscience for Methods and New Frontiers in Neuroscience Series (A. C. Michael, S. A. Simon & M. A. L. Nicolelis (Eds.)). (pp 1-15). Boca Raton, Fl., CRC Press. Bowden, 1985, Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid, Clin Pharmacol Ther, 37, 316, 10.1038/clpt.1985.46 Bunin, 1998, Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: and investigation of extrasynaptic transmission, J Neurosci, 18, 4854, 10.1523/JNEUROSCI.18-13-04854.1998 Bunin, 1999, Paracrine neurotransmission in the CNS: Involvement of 5-HT, Trends Neurosci, 22, 377, 10.1016/S0166-2236(99)01410-1 Burgen, 1965, The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart, Br J Pharmacol, 25, 34 Busch, 1998, Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine and memantine, Mol Pharmacol, 54, 342, 10.1124/mol.54.2.342 Busch, 1996, Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1, FEBS Lett, 395, 153, 10.1016/0014-5793(96)01030-7 Butler, 1988, The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomized rats, Prog Neuro-Psychopharmacol Biol Psychiatry, 12, 585, 10.1016/0278-5846(88)90004-8 Byrne, 1998, Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments, J Clin Psychiatry, 59, 279, 10.4088/JCP.v59n0602 Callaghan, 2005, Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry, Neurochem Int, 47, 350, 10.1016/j.neuint.2005.04.026 Carboni, 2004, Dopamine reuptake by norepinephrine neurons: exception or rule?, Crit Rev Neurobiol, 16, 121, 10.1615/CritRevNeurobiol.v16.i12.130 Carboni, 2006, Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex, J Neurochem, 96, 473, 10.1111/j.1471-4159.2005.03556.x Carboni, 1990, Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals, J Neurochem, 55, 1067, 10.1111/j.1471-4159.1990.tb04599.x Carlsson, 1969, Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-a-ethyl-meta-tyramine, Eur J Pharmacol, 5, 357, 10.1016/0014-2999(69)90113-7 Caspi, 2003, Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene, Science, 301, 386, 10.1126/science.1083968 Chen, 2001, Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters, J Neurosci, 21, 6348, 10.1523/JNEUROSCI.21-16-06348.2001 Chen, 2008, Substrates dissociate dopamine transporter oligomers, J Neurochem, 105, 910, 10.1111/j.1471-4159.2007.05195.x Chen, 2007, Triple uptake inhibitors: therapeutic potential in depression and beyond, Expert Opin Investig Drugs, 16, 1365, 10.1517/13543784.16.9.1365 Clements, 1996, Transmitter time course in the synaptic cleft: Its role in central synaptic function, Trends Neurosci, 19, 163, 10.1016/S0166-2236(96)10024-2 Codd, 1987, Platelet serotonin uptake: Methods and strain differences, Biol Psychiatry, 44, 169 Collier, 1996, A novel function of polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders, Mol Psychiatry, 1, 453 Coppen, 1967, The biochemistry of affective disorders, Br J Psychiatry, 113, 1237, 10.1192/bjp.113.504.1237 Cragg, 2004, DAncing past the DAT at a DA synapse, Trends Neurosci, 27, 270, 10.1016/j.tins.2004.03.011 Critchley, 2005, Mental stress and sudden cardiac death: asymmetric midbrain activity as a linking mechanism, Brain, 128, 75, 10.1093/brain/awh324 Cryan, 2005, Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test, Neurosci Behav Rev, 29, 547, 10.1016/j.neubiorev.2005.03.008 Dahlin, 2007, Expression and immunolocalization of the plasma membrane monoamine transporter in the brain, Neuroscience, 146, 1193, 10.1016/j.neuroscience.2007.01.072 Daws, 2000, 5-HT1B receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo, J Neurochem, 75, 2113, 10.1046/j.1471-4159.2000.0752113.x Daws, 2006, Ethanol inhibits clearance of brain serotonin by a serotonin transporter independent mechanism, J Neurosci, 26, 6431, 10.1523/JNEUROSCI.4050-05.2006 Daws, 2005, Transport mechanisms governing clearance in vivo revealed by high-speed chronoamperometry, J Neurosci Methods, 143, 49, 10.1016/j.jneumeth.2004.09.011 Daws, L. C., & Toney, G. M. (2007). Voltammetric Methods to Study Kinetics and Mechanisms for Serotonin Clearance In Vivo. In Michael, A.C. & Borland, L.M. (Eds.), Electrochemical Methods in Neuroscience for Methods and New Frontiers in Neuroscience Series ( Michael, A.C., Simon, S.A. & Nicolelis, M.A.L. (Eds.)). (pp 63-81). Boca Raton, Fl., CRC Press. Daws, 1998, In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: Contributions of serotonin and norepinephrine transporters, J Pharmacol Exp Ther, 286, 967 Dutta, 2003, Dopamine transporter as target for drug development of cocaine dependence medications, Eur J Pharmacol, 479, 93, 10.1016/j.ejphar.2003.08.060 Eichhammer, 2003, Allelic variation in the serotonin transporter promoter affects the neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI), Psychopharmacology, 166, 294, 10.1007/s00213-002-1370-1 Engel, 2005, Interaction of organic cations with a newly identified plasma membrane monoamine transporter, Mol Pharmacol, 68, 1397, 10.1124/mol.105.016832 Engel, 2004, Identification and characterization of a novel monoamine transporter in the human brain, J Biol Chem, 279, 50042, 10.1074/jbc.M407913200 Esler, 2004, Is essential hypertension sometimes a psychosomatic disorder?, J Hypertens, 22, 873, 10.1097/00004872-200405000-00003 Feinn, 2005, Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence, Am J Med Genet B Neuropsychiatry Genet, 133, 79, 10.1002/ajmg.b.30132 Feng, 2005, Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus, Brain Res, 1063, 69, 10.1016/j.brainres.2005.09.016 Fleckenstein, 2007, New insights into the mechanism of action of amphetamines, Annu Rev Pharmacol Toxicol, 47, 681, 10.1146/annurev.pharmtox.47.120505.105140 Frazer, 1997, Pharmacology of antidepressants, J Clin Psychopharmacol, 17, 2S, 10.1097/00004714-199704001-00002 Fuxe, 1991, Two principle modes of electrochemical communication in the brain: Volume versus wiring transmission, 1 Fuxe, 2007, From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission, Brain Res Rev, 55, 17, 10.1016/j.brainresrev.2007.02.009 Fuxe, 1967, Localization of 5-hydroxtryptamine uptake in rat brain after intraventricular injection, J Pharm Pharmacol, 19, 335, 10.1111/j.2042-7158.1967.tb08097.x Galli, 1996, Norepinephrine transporters have channel modes of conduction, Proc Natl Acad Sci USA, 93, 8671, 10.1073/pnas.93.16.8671 Gardier, 1996, Role of 5-HT1A autoreceptors in the mechanism of action of serotonergic antidepressant drugs: recent findings from in vivo microdialysis studies, Fundam Clin Pharmacol, 10, 16, 10.1111/j.1472-8206.1996.tb00145.x Gasser, 2006, Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: Potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission, J Neurosci, 26, 8758, 10.1523/JNEUROSCI.0570-06.2006 Gether, 2006, Neurotransmitter transporters: molecular function of important drug targets, Trends Pharmacol Sci, 27, 375, 10.1016/j.tips.2006.05.003 Giros, 1993, Molecular characterization of the dopamine transporter, Trends Pharmacol Sci, 14, 43, 10.1016/0165-6147(93)90029-J Glowinski, 1966, Effects of drugs on the disposition of H-3-norepinephrine in the rat brain, Pharmacol Rev, 18, 775 Gorboulev, 1997, Cloning and characterization of two human polyspecific organic cation transporters, DNA Cell Biol, 16, 871, 10.1089/dna.1997.16.871 Gründemann, 1997, Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells, J Biol Chem, 272, 10408, 10.1074/jbc.272.16.10408 Gründemann, 1994, Drug excretion mediated by a new prototype of polyspecific transporter, Nature, 372, 549, 10.1038/372549a0 Gründemann, 1998, Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter, Nat Neurosci, 1, 349, 10.1038/1557 Hariri, 2006, Genetics of emotional regulation: The role of the serotonin transporter in neural function, Trends Cogn Sci, 10, 182, 10.1016/j.tics.2006.02.011 Hendley, 1970, 3H-normetanephrine uptake in rat brain slices. Relationship to extraneuronal accumulation of norepinephrine, Eur J Pharmacol, 12, 167, 10.1016/0014-2999(70)90062-2 Henn, 1971, Glial cell function: uptake of transmitter substances, Proc Natl Acad Sci USA, 68, 2686, 10.1073/pnas.68.11.2686 Hoffman, 1991, Cloning of a serotonin transporter affected by antidepressants, Science, 254, 579, 10.1126/science.1948036 Holmes, 2003, Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background, Genes Brain Behav, 2, 365, 10.1046/j.1601-1848.2003.00050.x Holmes, 2002, Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter, Neuropsychopharmacology, 27, 914, 10.1016/S0893-133X(02)00374-3 Hrdina, 1981, Pharmacological characterization of [3H] desipramine binding in rat cerebral cortex, Prog Neuropsychopharmacol, 5, 553, 10.1016/0364-7722(81)90045-X Hughes, 1998, Evidence from microdialysis and synaptosomal studies of rat cortex for noradrenergic uptake sites with different sensitivities to SSRIs, Br J Pharmacol, 124, 1141, 10.1038/sj.bjp.0701947 Iversen, 2006, Neurotransmitter transporters and their impact on the development of psychopharmacology, Br J Pharmacol, 147, S82, 10.1038/sj.bjp.0706428 Jackson, 1995, Dynamics of 5-hydroxytryptamine released from dopamine neurons in caudate putamen of the rat, Brain Res, 674, 163, 10.1016/0006-8993(95)00019-M Jones, 1998, Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter, J Neurosci, 18, 1979, 10.1523/JNEUROSCI.18-06-01979.1998 Kahlig, 2005, Amphetamine induces dopamine efflux through a dopamine transporter channel, Proc Natl Acad Sci USA, 102, 3495, 10.1073/pnas.0407737102 Kannari, 2006, Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters, Neurosci Lett, 402, 62, 10.1016/j.neulet.2006.03.059 Kirsch, 2008, Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration, PLoS Med, 5, 260, 10.1371/journal.pmed.0050045 Kitaichi, 2005, Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice, Neurosci Lett, 382, 195, 10.1016/j.neulet.2005.03.014 Kobayashi, 2008, Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study, Psychopharmacology, 197, 567, 10.1007/s00213-008-1070-6 Koepsell, 2004, The SLC22 drug transporter family, Pflugers Arch, 477, 666, 10.1007/s00424-003-1089-9 Koepsell, 2007, Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications, Pharm Res, 24, 1227, 10.1007/s11095-007-9254-z Koepsell, 2003, Organic cation transporters, Rev Physiol Biochem Pharmacol, 150, 36, 10.1007/s10254-003-0017-x Kristufek, 2002, Organic cation transporter mRNA and function in the rat superior cervical ganglion, J Physiol, 543, 117, 10.1113/jphysiol.2002.021170 Lapin, 1969, Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect, Lancet, 1, 132, 10.1016/S0140-6736(69)91140-4 Lesch, 2005, Alcohol dependence and gene x environment interaction in emotion regulation: Is serotonin the link?, Eur J Pharmacol, 526, 113, 10.1016/j.ejphar.2005.09.027 Lesch, 1996, Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region, Science, 274, 1527, 10.1126/science.274.5292.1527 Lichtensteiger, 1967, Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines, J Neurochem, 14, 489, 10.1111/j.1471-4159.1967.tb09548.x Liprando, 2004, Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area, Synapse, 52, 233, 10.1002/syn.20023 Mandela, 2006, The norepinephrine transporter and its regulation, J Neurochem, 97, 310, 10.1111/j.1471-4159.2006.03717.x Männistö, 1999, Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors, Pharmacol Rev, 51, 593 Masson, 1999, Neurotransmitter transporters in the central nervous system, Pharmacol Rev, 51, 439 Maswood, 1999, Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: Role of the serotonin transporter and terminal autoreceptors, Brain Res, 831, 146, 10.1016/S0006-8993(99)01439-0 Mathews, 2004, Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression, J Neurosci Methods, 140, 169, 10.1016/j.jneumeth.2004.05.017 Mathews, 2006, No role of the dopamine transporter in acute ethanol effects on striatal dopamine dynamics, Synapse, 60, 288, 10.1002/syn.20301 Miner, 2000, Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals, J Comp Neurol, 427, 220, 10.1002/1096-9861(20001113)427:2<220::AID-CNE5>3.0.CO;2-P Miner, 2003, Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals, J Comp Neurol, 466, 478, 10.1002/cne.10898 Miranda, 2007, Regulation of receptors and transporters by ubiquitination: new insights into surprisingly similar mechanisms, Mol Interv, 7, 157, 10.1124/mi.7.3.7 Moll, 2000, Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life into late adulthood, Brain Res Dev Brain Res, 119, 251, 10.1016/S0165-3806(99)00182-0 Montañez, 2003, Exaggerated effects of fluvoxamine in heterozygote serotonin transporter knockout mice, J Neurochem, 86, 210, 10.1046/j.1471-4159.2003.01836.x Montgomery, 2008, The under-recognized role of dopamine in the treatment of major depressive disorder, Int Clin Psychopharmacol, 23, 63, 10.1097/YIC.0b013e3282f2b3cb Mooney, 2008, Enhanced norepinephrine output during long-term desipramine treatment: A possible role for the extraneuronal monoamine transporter (SLC22A3), J Psychiatr Res, 42, 605, 10.1016/j.jpsychires.2007.07.009 Morón, 2002, Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines, J Neurosci, 22, 389, 10.1523/JNEUROSCI.22-02-00389.2002 Mössner, 2006, Aberrant accumulation of serotonin in dopamine neurons, Neurosci Lett, 401, 49, 10.1016/j.neulet.2006.02.081 Munafò, 2008, Serotonin transporter (5-HTTLPR) genotype and amygdala activation: A meta analysis, Biol Psychiatry, 63, 852, 10.1016/j.biopsych.2007.08.016 Murphy, 2008, Targeting the murine serotonin transporter: insights into human neurobiology, Nat Rev Neurosci, 9, 85, 10.1038/nrn2284 Nakayama, 2007, The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats, Brain Res, 1184, 260, 10.1016/j.brainres.2007.09.072 Nicholson, 1995, Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatum, Biophys J, 68, 1699, 10.1016/S0006-3495(95)80348-6 Nirenberg, 1997, The dopamine transporter: Comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens, J Neurosci, 17, 6899, 10.1523/JNEUROSCI.17-18-06899.1997 Nirenberg, 1996, The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons, J Neurosci, 16, 436, 10.1523/JNEUROSCI.16-02-00436.1996 Nutt, 2006, The role of dopamine and norepinephrine in depression and antidepressant treatment, J Clin Psychiatry, 67, 3 Pacholczyk, 1991, Expression and cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter, Nature, 350, 350, 10.1038/350350a0 Pan, 2001, Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice, Brain Res Dev Brain Res, 126, 125, 10.1016/S0165-3806(00)00145-0 Pickel, 1999, Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens, J Neurosci, 19, 7356, 10.1523/JNEUROSCI.19-17-07356.1999 Prange, 1964, The pharmacology and biochemistry of depression, Dis Nerv Syst, 25, 217 Ramamoorthy, 1999, Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants, Science, 285, 763, 10.1126/science.285.5428.763 Raiteri, 1977, Effects of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptramine, Eur J Pharmacol, 41, 133, 10.1016/0014-2999(77)90202-3 Rausch, 2005, Initial conditions of psychotropic drug response: Studies of serotonin transporter long promoter region (5-HTTLPR), serotonin transporter efficiency, cytokine and kinase gene expression relevant to depression and antidepressant outcome, Prog Neuropsychopharmacol Biol Psychiatr, 29, 1046, 10.1016/j.pnpbp.2005.03.011 Rausch, 2002, Initial conditions of serotonin transporter kinetics and genotype: Influence on SSRI treatment trial outcome, Biol Psychiatry, 51, 723, 10.1016/S0006-3223(01)01283-5 Robinson, 2002, Regulated trafficking of neurotransmitter transporters: common notes but different melodies, J Neurochem, 80, 1, 10.1046/j.0022-3042.2001.00698.x Ross, 1969, Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue, Eur J Pharmacol, 7, 270, 10.1016/0014-2999(69)90091-0 Schenk, 2002, The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate, Prog Drug Res, 59, 111, 10.1007/978-3-0348-8171-5_4 Schildkraut, 1965, The catecholamine hypothesis of affective disorders: A review of supporting evidence, Am J Psychiatr, 122, 509, 10.1176/ajp.122.5.509 Schildkraut, 2004, Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis, Am J Psychiatr, 161, 909, 10.1176/appi.ajp.161.5.909 Schmitt, 2003, Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice, J Neurosci Res, 71, 701, 10.1002/jnr.10521 Schroeter, 2000, Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter, J Comp Neurol, 420, 211, 10.1002/(SICI)1096-9861(20000501)420:2<211::AID-CNE5>3.0.CO;2-3 Serretti, 2007, Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients, Mol Psychiatry, 12, 247, 10.1038/sj.mp.4001926 Shaskan, 1970, Kinetics of serotonin accumulation into slices from rat brain: Relationship to catecholamine uptake, J Pharmacol Exp Ther, 175, 404 Shen, 2004, Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters, Neuropsychopharmacology, 29, 1790, 10.1038/sj.npp.1300476 Sitte, 2004, Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking, Mol Interv, 4, 38, 10.1124/mi.4.1.38 Skolnick, 2006, Preclinical and clinical pharmacology of DOV 216, 303, a “triple” reuptake inhibitor, CNS Drug Rev, 12, 123, 10.1111/j.1527-3458.2006.00123.x Smits, 2004, Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review, Mol Psychiatry, 9, 433, 10.1038/sj.mp.4001488 Stamford, 1990, Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data, Brain Res, 515, 173, 10.1016/0006-8993(90)90593-Z Stanford, 1996, Prozac: panacea or puzzle?, Trends Pharmacol Sci, 17, 150, 10.1016/0165-6147(96)81591-4 Steiner, 2008, Going with the flow: Trafficking-dependent and -independent regulation of serotonin transport, Traffic, 9, 1393, 10.1111/j.1600-0854.2008.00757.x Stone, 2008, An anti-immobility effect of exogenous corticosterone in mice, Eur J Pharmacol, 580, 135, 10.1016/j.ejphar.2007.10.045 Streich, 1996, Expression of the extraneuronal monoamine transporter (uptake 2) in human glioma cells, Naunyn Schmeideberg's Arch Pharmacol, 353, 328, 10.1007/BF00168636 Sulzer, 2005, Antidepressants and the monoamine masquerade, Neuron, 46, 1, 10.1016/j.neuron.2005.03.013 Sur, 1996, Immunocytochemical detection of the serotonin transporter in rat brain, Neuroscience, 73, 217, 10.1016/0306-4522(96)00030-9 Swiergiel, 2008, Effects of chronic and acute stressors and CRF on depression-like behavior in mice, Behav Brain Res, 186, 32, 10.1016/j.bbr.2007.07.018 Tejani-Butt, 1992, [3H]Nisoxetine: A radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding, J Pharmacol Exp Ther, 260, 427 Torres, 2003, Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter, J Biol Chem, 278, 2731, 10.1074/jbc.M201926200 Torres, 2003, Plasma membrane monoamine transporters: structure, regulation and function, Nat Rev Neurosci, 4, 13, 10.1038/nrn1008 Vialou, 2004, Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation, J Neurosci, 24, 2846, 10.1523/JNEUROSCI.5147-03.2004 Vialou, 2007, Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain, Neuroscience, 144, 616, 10.1016/j.neuroscience.2006.09.058 Vizi, 2004, Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: Implications for the action of selective serotonin reuptake inhibitors, J Neurosci, 24, 7888, 10.1523/JNEUROSCI.1506-04.2004 Whitby, 1961, The fate of 3H-norepinephrine in animals, J Pharmacol Exp Ther, 132, 193 Wightman, 1990, Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake, Brain Res Brain Res Rev, 15, 135, 10.1016/0165-0173(90)90015-G Wilhelm, 2006, Life events, first depression onset and the serotonin transporter gene, Br J Psychiatry, 188, 210, 10.1192/bjp.bp.105.009522 Williams, 2001, Central nervous system serotonin function and cardiovascular responses to stress, Psychosom Med, 63, 300, 10.1097/00006842-200103000-00016 Wu, 1998, Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake 2) and evidence for the expression of the transporter in brain, J Biol Chem, 273, 32776, 10.1074/jbc.273.49.32776 Wurtman, 2005, Genes, stress and depression, Metabolism, 54, 16, 10.1016/j.metabol.2005.01.007 Zahniser, 1999, In vivo dopamine clearance in rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors, J Pharmacol Exp Ther, 289, 266 Zahniser, 2004, Rapid regulation of the dopamine transporter: Role in stimulant addiction, Neuropharmacology, 47, S80, 10.1016/j.neuropharm.2004.07.010 Zhou, 2007, Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain, Biochem Pharmacol, 72, 147, 10.1016/j.bcp.2006.09.008 Zhou, 2005, Corelease of dopamine and serotonin from striatal dopamine terminals, Neuron, 46, 65, 10.1016/j.neuron.2005.02.010 Zhou, 2002, Serotonin uptake into dopamine neurons via dopamine transporters: A compensatory alternative, Brain Res, 942, 109, 10.1016/S0006-8993(02)02709-9 Zhou, 1998, Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence, Brain Res, 805, 241, 10.1016/S0006-8993(98)00691-X